TRIAMCINOLONE ACETONIDE | A208590 | ENCUBE ETHICALS PRIVATE LTD
No patent or exclusivity listings for this strength.
ENCUBE acquired rights to triamcinolone acetonide oral suspension (NDA 208590), replacing PAI Holdings Pharm as the listed applicant.
Old: PAI HOLDINGS PHARM
New: ENCUBE
ENCUBE Ethicals Private Ltd replaced PAI Holdings LLC as the applicant for triamcinolone acetonide NDA 208590.
Old: PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC
New: ENCUBE ETHICALS PRIVATE LTD